FDA Approved: AJOVY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AJOVY (fremanezumab-vfrm) from Teva, updating its labeling to reflect the approved supplemental use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine Chronic
• Migraine Episodic

Drugs mentioned

• Ajovy (fremanezumab)

Snippet

SUPPL AP for AJOVY (FREMANEZUMAB-VFRM)